Early research (Phase 1)Study completedNCT00003548What this trial is testingAminocamptothecin in Treating Patients With Advanced Cancer of the Peritoneal CavityWho this might be right forCancer NYU Langone Health 20
Not applicableStudy completedNCT00477919What this trial is testingE-MOSAIC Electronic Tool to Monitor SymptomsWho this might be right forCancer Swiss Cancer Institute 264
Testing effectiveness (Phase 2)Study completedNCT00353015What this trial is testingIrinotecan and Cisplatin for High Grade Neuroendocrine Carcinoma of the Gastrointestinal TractWho this might be right forGastrointestinal CancerCarcinoma, Neuroendocrine M.D. Anderson Cancer Center 21
Large-scale testing (Phase 3)UnknownNCT00003558What this trial is testingChemotherapy in Treating Patients With Cancer of Unknown Primary OriginWho this might be right forCarcinoma of Unknown Primary Academisch Ziekenhuis Maastricht 140
Early research (Phase 1)Looking for participantsNCT07118176What this trial is testingDetermining the Biodistribution of an Imaging Tracer (68Ga-FAPi-46) in Patients With Solid Tumors or Hematologic CancersWho this might be right forAnal CarcinomaBladder CarcinomaBreast Carcinoma+31 more Jonsson Comprehensive Cancer Center 30
Large-scale testing (Phase 3)UnknownNCT00022178What this trial is testingCombination Chemotherapy in Treating Patients With Metastatic Cancer of an Unknown Site of OriginWho this might be right forCarcinoma of Unknown Primary The Christie NHS Foundation Trust
Early research (Phase 1)Study completedNCT00004074What this trial is testingInterleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/NeuWho this might be right forAdvanced Adult Primary Liver CancerAnaplastic Thyroid CancerBone Metastases+124 more National Cancer Institute (NCI) 15
Not applicableLooking for participantsNCT04504604What this trial is testingTCF-001 TRACK (Target Rare Cancer Knowledge) StudyWho this might be right forRare CancersCholangiocarcinomaCancer of Unknown Primary Site TargetCancer Foundation 400
Testing effectiveness (Phase 2)Ended earlyNCT00003526What this trial is testingAntineoplaston Therapy in Treating Patients With Cancer of Unknown Primary OriginWho this might be right forUnknown Primary Carcinoma Burzynski Research Institute 8
Testing effectiveness (Phase 2)Study completedNCT00004922What this trial is testingIrinotecan in Treating Patients With Advanced Neuroendocrine TumorsWho this might be right forCarcinoma of Unknown PrimaryNeuroendocrine CarcinomaNeuroendocrine Carcinoma of the Skin Memorial Sloan Kettering Cancer Center
Not applicableApproved For MarketingNCT04100694What this trial is testingEarly Access Program Providing HER2/HER3 Bispecific Antibody, MCLA-128, for a Patient With Advanced NRG1-Fusion Positive Solid TumorWho this might be right forNRG1 FusionPancreatic CancerNon Small Cell Lung Cancer+8 more Merus B.V.
Testing effectiveness (Phase 2)Ended earlyNCT00201734What this trial is testingCapecitabine, Carboplatin and Weekly Paclitaxel for Patients With Solid Tumors and Adenocarcinoma of Unknown PrimaryWho this might be right forTumorsUnknown Primary TumorsAdenocarcinoma Ohio State University Comprehensive Cancer Center 57
Testing effectiveness (Phase 2)Study completedNCT00191503What this trial is testingGemcitabine and Pemetrexed in Primary Unknown AdenocarcinomaWho this might be right forAdenocarcinoma Eli Lilly and Company 30
Very early researchEnded earlyNCT00499733What this trial is testingCyclophosphamide and Cryoablation in Treating Patients With Advanced or Metastatic Epithelial CancerWho this might be right forCancer Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 19
Testing effectiveness (Phase 2)Active Not RecruitingNCT02978625What this trial is testingTalimogene Laherparepvec and Nivolumab in Treating Patients With Refractory Lymphomas or Advanced or Refractory Non-melanoma Skin CancersWho this might be right forAnaplastic Large Cell Lymphoma, ALK-NegativeAnaplastic Large Cell Lymphoma, ALK-PositiveApocrine Carcinoma+36 more National Cancer Institute (NCI) 68
Testing effectiveness (Phase 2)Active Not RecruitingNCT02713269What this trial is testingThermal Ablation and Spine Stereotactic Radiosurgery in Treating Patients With Spine Metastases at Risk for Compressing the Spinal CordWho this might be right forMalignant Digestive System NeoplasmMetastatic Head and Neck CarcinomaMetastatic Kidney Carcinoma+10 more M.D. Anderson Cancer Center 60
Testing effectiveness (Phase 2)Looking for participantsNCT04325425What this trial is testingChemotherapy For Metastatic Grade 3 Poorly Differentiated NEuroendocrine Carcinoma Of GastroEnteroPancreatic And Unknown PrimaryWho this might be right forNeuroendocrine Carcinoma Centre Hospitalier Universitaire Dijon 218
Early research (Phase 1)Study completedNCT00005842What this trial is testingTrastuzumab Plus R115777 in Treating Patients With Advanced or Metastatic CancerWho this might be right forCancer National Cancer Institute (NCI) 24
Testing effectiveness (Phase 2)Study completedNCT02820857What this trial is testingAssessment of the Efficacy of Bevacizumab in Combination With Folfiri as Second-line Treatment in Patients Suffering From an Advanced Inoperable Poorly Differentiated Neuroendocrine Carcinoma of an Unknown or Gastroentero-pancreatic Primary CancerWho this might be right forNeuroendocrine Carcinomas Hospices Civils de Lyon 153
Testing effectiveness (Phase 2)Study completedNCT00004005What this trial is testingIrinotecan Followed By Fluorouracil and Leucovorin in Treating Patients With Stage III or Stage IV Colorectal Carcinoma (Cancer), Other Refractory Carcinoma, or Metastatic Adenoma (Cancer) of Unknown Primary OriginWho this might be right forCarcinoma of Unknown PrimaryColorectal CancerUnspecified Adult Solid Tumor, Protocol Specific+1 more St. Jude Children's Research Hospital 12